Correction: M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
Main Authors: | Valérie Martel-Laferrière, Daniel J. Feaster, Lisa R. Metsch, Bruce R. Schackman, Christine Loignon, Bohdan Nosyk, Hansel Tookes, Czarina N. Behrends, Nelson Arruda, Oluleye Adigun, Marie-Eve Goyer, Michael A. Kolber, Jean-Francois Mary, Allan E. Rodriguez, Iveth G. Yanez, Yue Pan, Rania Khemiri, Lauren Gooden, Aïssata Sako, Julie Bruneau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Trials |
Online Access: | https://doi.org/10.1186/s13063-022-06724-9 |
Similar Items
-
M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
by: Valérie Martel-Laferrière, et al.
Published: (2022-04-01) -
HCV Treatment Outcomes in PWID: Impact of Addiction History on SVR12
by: Ivana Milošević, et al.
Published: (2024-12-01) -
Oral antibiotic therapy in people who inject drugs (PWID) with bacteraemia
by: Aurélien Emmanuel Martinez, et al.
Published: (2020-06-01) -
7 Differences in physiological/metabolic parameters and mortality between people who inject drugs (PWID) and non PWID, with Staphylococcus aureus blood stream infection; A retrospective case note review
by: Isabel Mortimer, et al.
Published: (2022-09-01) -
Correction: Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID).
by: PLOS One Staff
Published: (2024-01-01)